EKOS Adds $5 Million

EKOS Corp., a maker of drug delivery catheters based on ultrasound technology, has raised $5 million in new Series C funding, according to a regulatory filing. No investor information was disclosed, except that existing shareholders include ARCH Venture Partners, Bessemer Venture Partners, Merrill Lynch, Mitsui & Co., Spray Venture Partners, MedVenture Associates, Protostar, Technology Partners and Morgan Stanley Venture Partners.

 

The Bothell, Wash.-based had previously raised over $86 million. www.ekoscorp.com